Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia

Documenti analoghi

• Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity
  di: Igor Makarenko, et al.
  Pubblicazione: (2024)
• Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar
  di: Anait L. Melikyan, et al.
  Pubblicazione: (2025)
• Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure
  di: Ekaterina Koksharova, et al.
  Pubblicazione: (2024)
• Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
  di: Sergei Noskov, et al.
  Pubblicazione: (2024)
• A Single Institutional Experience Using Romiplostim to Treat Therapy‐Related Thrombocytopenia in Pediatric Solid Tumor Patients
  di: Melanie D. Degliuomini, et al.
  Pubblicazione: (2025)